clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Braden B | The best and worst treatments for Helicobacter pylori. | 2015 | BMJ | pmid:26290321 |
| Li BZ et al. | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. | 2015 | BMJ | pmid:26290044 |
| Haider RB et al. | A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population. | 2015 | Eur J Gastroenterol Hepatol | pmid:26287955 |
| Shallom SJ et al. | New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group. | 2015 | J. Clin. Microbiol. | pmid:26269619 |
| Zagari RM et al. | Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. | 2015 | Dig Liver Dis | pmid:26253555 |
| Kozan G et al. | Effect of systemic clarithromycin and prednisolone on histamine-induced otitis media in guinea pigs. | 2015 | Acta Otolaryngol. | pmid:26143935 |
| Ferro BE et al. | Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease. | 2015 | J. Antimicrob. Chemother. | pmid:26142475 |
| Honda M et al. | Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial. | 2015 | J. Am. Coll. Surg. | pmid:26141464 |
| Matsumoto T et al. | Mycobacterium fortuitum thoracic empyema: A case report and review of the literature. | 2015 | J. Infect. Chemother. | pmid:26139179 |
| Losurdo G et al. | Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'. | 2015 | Int. J. Clin. Pract. | pmid:26138290 |
| Reveiz L and Cardona AF | Antibiotics for acute laryngitis in adults. | 2015 | Cochrane Database Syst Rev | pmid:26002823 |
| Zhang T | Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites. | 2015 | Eur J Pharm Sci | pmid:26116278 |
| Fraser LA et al. | Calcium channel blocker-clarithromycin drug interaction did not increase the risk of nonvertebral fracture: a population-based study. | 2015 | Ann Pharmacother | pmid:25429094 |
| Lee SJ et al. | Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice. | 2015 | PLoS ONE | pmid:26114656 |
| Dimer F et al. | Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections. | 2015 | Pharm. Res. | pmid:26113237 |
| Kasai A et al. | Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011. | 2015 | J. Med. Microbiol. | pmid:25934551 |
| Mahmoudi A et al. | Microbiological assay for the analysis of certain macrolides in pharmaceutical dosage forms. | 2015 | Int J Pharm | pmid:26112961 |
| Flores-Gonzalez JC et al. | [Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)]. | 2015 | Rev Neurol | pmid:26108903 |
| Tojima I et al. | Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium. | 2015 | Auris Nasus Larynx | pmid:25769240 |
| Nonaka L et al. | Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site. | 2015 | Lett. Appl. Microbiol. | pmid:25765542 |
| Srivastava AK et al. | In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation. | 2015 | Arch. Pharm. (Weinheim) | pmid:25996140 |
| Koh WJ et al. | Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. | 2015 | Antimicrob. Agents Chemother. | pmid:25987622 |
| Tsunemine H et al. | [Successful treatment of relapsed and refractory multiple myeloma by using clarithromycin-lenalidomide, low-dose dexamethasone(BiRd), and melphalan-prednisolone(MP)]. | 2015 | Gan To Kagaku Ryoho | pmid:25981655 |
| Ribaldone DG et al. | Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy. | 2015 | Panminerva Med | pmid:25971330 |
| Thellin O et al. | In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media. | 2015 | Int. J. Antimicrob. Agents | pmid:25963337 |
| Hwang JJ et al. | Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. | 2015 | World J. Gastroenterol. | pmid:25945019 |
| Liou JM et al. | The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study. | 2015 | PLoS ONE | pmid:25942450 |
| Ferreri AJ et al. | High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. | 2015 | Ann. Oncol. | pmid:25935794 |
| Ito A et al. | Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital. | 2015 | J. Med. Microbiol. | pmid:25934550 |
| Burton AJ et al. | Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. | 2015 | Antimicrob. Agents Chemother. | pmid:25824218 |
| Kazama I et al. | Macroscopic haemoglobinuria associated with Mycoplasma pneumoniae infection successfully treated by clarithromycin. | 2015 | Infez Med | pmid:25819056 |
| Silva JT et al. | Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: case report and literature review. | 2015 | Transpl Infect Dis | pmid:25816889 |
| Sugawara M et al. | Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. | 2015 | J. Dermatol. | pmid:25809502 |
| Andrianov M et al. | A 15-year-old boy with abdominal pain, growth retardation, and anemia secondary to Helicobacter pylori-associated peptic ulcer. | 2015 | Pediatr Ann | pmid:25806733 |
| Zhao C et al. | [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. | 2015 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:25791651 |
| Molina-Infante J et al. | Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study. | 2015 | Aliment. Pharmacol. Ther. | pmid:25776067 |
| Takahashi C et al. | Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid. | 2015 | Microscopy (Oxf) | pmid:25757698 |
| Metanat HA et al. | Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial. | 2015 | Helicobacter | pmid:25752357 |
| Essilfie AT et al. | Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. | 2015 | Thorax | pmid:25746630 |
| Bouilhat N et al. | High-level primary clarithromycin resistance of Helicobacter pylori in Morocco: a prospective multicenter molecular study. | 2015 | Helicobacter | pmid:25735573 |
| Guzman Vinasco L et al. | Acute suppurative parotitis caused by Streptococcus pneumoniae in an HIV-infected man. | 2015 | BMJ Case Rep | pmid:25733094 |
| Mitsui Y et al. | Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication. | 2015 | Clin J Gastroenterol | pmid:25733031 |
| Zhou Z et al. | Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. | 2015 | Antimicrob. Agents Chemother. | pmid:25451048 |
| Hur J et al. | Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | 2015 | Chem. Res. Toxicol. | pmid:25811541 |
| Liu Q et al. | Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection. | 2015 | Eur J Gastroenterol Hepatol | pmid:25629566 |
| Genc G et al. | Does systemic clarithromycin therapy have an inhibitory effect on tympanosclerosis? An experimental animal study. | 2015 | J Laryngol Otol | pmid:25619629 |
| Winkel P et al. | Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial. | 2015 | Int. J. Cardiol. | pmid:25602299 |
| Trespalacios AA et al. | Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. | 2015 | Diagn. Microbiol. Infect. Dis. | pmid:25600075 |
| Galvidis I et al. | Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes. | 2015 | Anal. Biochem. | pmid:25256165 |
| Yoshida S et al. | Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes. | 2015 | J. Med. Microbiol. | pmid:25596119 |
| Siekmeier R et al. | Inhalation of macrolides: a novel approach to treatment of pulmonary infections. | 2015 | Adv. Exp. Med. Biol. | pmid:25252902 |
| Ontsira Ngoyi EN et al. | Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo. | 2015 | Helicobacter | pmid:25585658 |
| Spaniol V et al. | Moraxella catarrhalis AcrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response. | 2015 | Antimicrob. Agents Chemother. | pmid:25583725 |
| Chu HS et al. | Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. | 2015 | PLoS ONE | pmid:25581038 |
| Lee HJ et al. | Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. | 2015 | World J. Gastroenterol. | pmid:25574111 |
| Phan TN et al. | High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. | 2015 | Int. J. Antimicrob. Agents | pmid:25499186 |
| Adebisi AO et al. | Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. | 2015 | J. Pharm. Pharmacol. | pmid:25496042 |
| Tsay FW et al. | Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. | 2015 | Helicobacter | pmid:25495272 |
| Mourad-Baars PE et al. | Low antibiotic resistance of Helicobacter pylori in The Netherlands. | 2015 | Helicobacter | pmid:25495199 |
| Frija-Masson J et al. | [Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. | 2015 | Rev Mal Respir | pmid:25480387 |
| Lee H et al. | Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea. | 2015 | Dig Liver Dis | pmid:25467826 |
| Kobayashi M et al. | A sudden cardiac death induced by sildenafil and sexual activity in an HIV patient with drug interaction, cardiac early repolarization, and arrhythmogenic right ventricular cardiomyopathy. | 2015 | Int. J. Cardiol. | pmid:25464498 |
| Boltin D et al. | Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned? | 2015 | J. Clin. Microbiol. | pmid:25428158 |
| Moriya S et al. | Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells. | 2015 | Int. J. Oncol. | pmid:25422130 |
| Dierig A et al. | Antibiotic treatment of pertussis: are 7 days really sufficient? | 2015 | Pediatr. Infect. Dis. J. | pmid:25247586 |
| Zhang Y et al. | Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China. | 2015 | Carcinogenesis | pmid:26449252 |
| Mailleux M et al. | Unusual pulmonary toxicity of ipilimumab treated by macrolides. | 2015 | Acta Clin Belg | pmid:26790556 |
| Gisbert JP et al. | Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy. | 2015 | Dig. Dis. Sci. | pmid:25236423 |
| Ersal T et al. | Fatal disseminated infection with Fusarium petroliphilum. | 2015 | Mycopathologia | pmid:25234793 |
| Tongtawee T et al. | High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand. | 2015 | Asian Pac. J. Cancer Prev. | pmid:26745073 |
| Jesus FP et al. | In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. | 2015 | Antimicrob. Agents Chemother. | pmid:26459895 |
| Higuchi K et al. | Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study. | 2015 | Gastric Cancer | pmid:25098924 |
| Baumann M et al. | Aquatic toxicity of the macrolide antibiotic clarithromycin and its metabolites. | 2015 | Chemosphere | pmid:25051235 |
| Shin SH et al. | Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. | 2015 | PLoS ONE | pmid:26580072 |
| Desai S et al. | The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013. | 2015 | PLoS ONE | pmid:26569613 |
| Kakked GA et al. | Pneumobilia with gastric outlet obstruction. | 2015 | BMJ Case Rep | pmid:26552878 |
| Kim SE et al. | Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy. | 2015 | Korean J. Intern. Med. | pmid:26552455 |
| Bang CS and Baik GH | Time to learn from the past and prepare for the future in Helicobacter pylori eradication. | 2015 | Korean J. Intern. Med. | pmid:26552453 |
| Alimadadi M et al. | Impact of creatinine clearance on Helicobacter pylori eradication rate in patients with peptic ulcer disease. | 2015 | Iran J Kidney Dis | pmid:26552348 |
| Karpiński TM et al. | Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland. | 2015 | Acta Microbiol Immunol Hung | pmid:26551571 |
| Rose WE et al. | Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination. | 2015 | Pharm. Res. | pmid:24934663 |
| Nishizawa T et al. | Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan. | 2015 | J. Clin. Gastroenterol. | pmid:24921211 |
| Wu IT et al. | Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. | 2015 | World J. Gastroenterol. | pmid:26457027 |
| Boyanova L et al. | Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance. | 2015 | Int. J. Antimicrob. Agents | pmid:26453146 |
| Rubio M et al. | Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. | 2015 | PLoS ONE | pmid:26448181 |
| Blair PW et al. | DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment. | 2015 | BMJ Case Rep | pmid:26438676 |
| Chen KY et al. | Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial. | 2015 | World J. Gastroenterol. | pmid:26420970 |
| Apiwattankul N et al. | Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. | 2015 | J Pediatric Infect Dis Soc | pmid:26407409 |
| Barni S et al. | Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. | 2015 | J Investig Allergol Clin Immunol | pmid:25997306 |
| Hwang JJ et al. | Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. | 2015 | World J. Gastroenterol. | pmid:26401089 |
| Zhi D et al. | The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. | 2015 | Eur J Pharm Sci | pmid:25976224 |
| Vliegenthart AD et al. | Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. | 2015 | Sci Rep | pmid:26489516 |
| Zhu YC et al. | Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus. | 2015 | Mol. Cell. Probes | pmid:26334290 |
| Georgopoulos SD et al. | Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era. | 2015 | Expert Opin Pharmacother | pmid:26330278 |
| Koide T et al. | Analysis of Distribution of Ingredients in Commercially Available Clarithromycin Tablets Using Near-Infrared Chemical Imaging with Principal Component Analysis and Partial Least Squares. | 2015 | Chem. Pharm. Bull. | pmid:26329859 |
| Nozawa K et al. | Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process. | 2015 | Int J Pharm | pmid:26325306 |
| Renvoisé A et al. | Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. | 2015 | Antimicrob. Agents Chemother. | pmid:26324275 |
| Dingemanse C et al. | Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. | 2015 | Carcinogenesis | pmid:26320104 |
| Obregón-Henao A et al. | Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models. | 2015 | Antimicrob. Agents Chemother. | pmid:26303795 |
| Pea F et al. | Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia. | 2015 | Transpl Infect Dis | pmid:26296391 |